Genmab — Maj 2025
-
ASCO 25 A phase 3, open-label, randomized study of rinatabart sesutecan (Rina-S) vs investigator’s choice (IC) of chemotherapy in patients with platinum-resistant ovarian cancer (PROC) https://meetings.asco.org/abstracts-presentations/252407
-
ASCO 25 Novel analysis of 3-y results from the pivotal EPCORE NHL-1 study: Outcomes in patients (pts) with relapsed/refractory large B-cell lymphoma (R/R LBCL) and complete response (CR) at 2 y with epcoritamab (epcor) monotherapy. https://meetings.asco.org/abstracts-presentations/246029
-
ASCO 25 First data from phase 1b/2 EPCORE NHL-4: Epcoritamab (Epcor) in Chinese patients (Pts) with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL). https://meetings.asco.org/abstracts-presentations/246176
-
Fra MW "Genmab vil over flere omgange præsentere data fra sin pipeline i forbindelse med årsmødet his American Society of Clinical Oncology (ASCO) i starten af juni.
Præsentationerne inkluderer den første offentliggørelse af resultater fra et fase 1/2-studie med Rina-S til behandling af kræft i livmoderen."
-
Johnson & Johnson showcases latest advancements in cancer innovation with more than 70 clinical and real-world studies at ASCO and EHA https://www.jnj.com/media-center/press-releases/johnson-johnson-showcases-latest-advancements-in-cancer-innovation-with-more-than-70-clinical-and-real-world-studies-at-asco-and-eha
-
How Insourcing Transformed Antibody Manufacturing Success https://bioprocessupdates.com/upstream/how-insourcing-transformed-antibody-manufacturing-success/
-
perplexity analysis Rina-S...not sure if this link will work for others...
: https://www.perplexity.ai/search/results-how-does-this-new-data-YPc0_alLR5iBhcEc4MOBsw -
Stort marked for behandling af endometrial cancer https://www.gminsights.com/industry-analysis/endometrial-cancer-treatment-market
-
Mere https://www.businessresearchinsights.com/market-reports/endometrial-cancer-market-119445 Gad vide om Rina-S kunne kombineres med f.eks. Keytruda ? Så kunne en first line kombo nok vise gode resultater. Hvis da ikke mono Rina-S var god alene. Husk Keytruda snart går off patent.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind